December 12-14, 2023 | Boston, MA
29 January – 1 February, 2023 | Vancouver, British Columbia
Ribonucleic acid (RNA) binding proteins (RBPs) are a significant group of regulators encoded in more than 2 000 human genes. In the last few years, the millions of interactions between protein and RNA in various cellular contexts have been tracked through ever-growing scalable technology that has provided opportunities for more connections to genetics and diseases. Additionally, remarkable advances in microscopy and structural methods have provided important insights into the interactions between proteins and RNA. The conference addresses the growing interest from both the translational and basic life science communities in imagining interactions between protein and RNA as a collection of novel biochemistry and a drug target.
Webinar: Supporting Therapeutic Development with Ribosome Profiling and miRNA Probing
In this webinar, we will discuss two assays that can assist in the development of RNA therapeutics: eRibo Pro™, a ribosome profiling assay for examining both transcription & translation in the same system, and miR-eCLIP +siRNA™, an eCLIP-based method for directly identifying where miRNAs & siRNAs associate with genes across the transcriptome.